Phathom Pharma Upgraded by Barclays to Overweight $18 Target
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
An index aggregates price movement to summarize market direction, helping traders and investors gauge momentum and risk.
28,440 articlesBarclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
OpenPayd’s Chief Commercial Officer explains how a unified financial infrastructure and growing stablecoins are accel...
ServiceNow's stock is down this year, but CEO Bill McDermott argues AI will accelerate growth, not derail it, outlini...
Ripple is in focus as XRP moves past a key resistance level amid upbeat market conditions. Analysts describe a potent...
In a sign of a sustained unwind, the bhutan government moves another tranche of BTC as 2026 outflows surge. Arkham re...
XRP steadies near key support and eyes a breakout above $1.60 this week. This week's ripple (xrp) price predicti...
Oil prices cooled modestly on May 14, 2026, with Brent trading around $107.82 per barrel. Analysts say the current pr...
AI reshapes entry-level work as automation accelerates, pushing colleges to rethink internships and hands-on experien...
Standard Chartered is moving to absorb Zodia Custody's crypto operations, extending its digital-asset platform. The d...
A leading retailer is quietly deploying AI to sharpen efficiency and customer service, signaling a stealth AI play fo...
IBM and Oracle have quietly strengthened AI backlogs and earnings, setting up a potential late-2026 surprise as marke...
BitGo and Galaxy Digital continue their in-court battle over a failed $1.2 billion merger, with BitGo seeking damages...